Skip to Main Content

Yet another drug maker has agreed in principle to pay a stiff fine to resolve an investigation into its relationships with patient charities. The latest company to do so is the U.S. subsidiary of Lundbeck (HLUYY), a Danish drug maker that will fork over $52.6 million.

The announcement comes two years after the U.S. Attorney issued a subpoena in connection with an investigation of payments that Lundbeck made to an unspecified number of charities that provided financial assistance to patients taking various medicines (see page 50).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!